October 27, 2008

BIOGEN IDEC: EC Continues Antitrust Probe on Competitive Modes

COMPANIES: Biogen Idec Inc
Subscribe

Biogen Idec Inc. continues to cooperate with the European Commission’s industry-wide antitrust inquiry into competitive conditions within the pharmaceutical sector.

As part of the inquiry that began on January 2008, the EC issued detailed questionnaires to about 100 companies, including the…

TO CONTINUE READING,LOGIN or
TOPICS: Drugs/Pharmaceuticals | Drugstores | Earnings | Health Care | Legal Issues, Litigation | Loans & Financing | Medical Supplies | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US | Supplementary Medicine
LOCATIONS: Massachusetts | North America | United States